April 21, 2026 Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
April 21, 2026 MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 21, 2026 Adams Security Group LLC Launches New Website to Expand Professional Security Services Across Florida
April 21, 2026 Becoming Independent Named No. 17 on “The NonProfit Times’ 2026 Best Nonprofits To Work For”
